Netherlands
Medizinprodukt-Marktintelligenz für Netherlands. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Neueste Signale
Philips warns that Azurion systems' float tabletop control may suffer mechanical wear, affecting table movement.
The GATE Trial evaluates endoscopic sutured gastroplasty's effect on glycemic control in obese type 2 diabetes patients.
A completed pilot study evaluated the TriGuard™HDH device during TAVR in 12 patients in the Netherlands.
An observational study will assess AI's role in using wearables to detect deterioration in advanced heart failure patients.
The clinical trial tested the tolerance and practicality of the Module AOX device in critically ill patients.
Philips Ultrasound LLC registered the Extended Compact Cart under Class I in EUDAMED with UDI-DI 00884838111721.
The BeneMACS study shows HeartMate II LVAD survival in non-transplant patients is equal or better than literature results.
A completed study evaluated the Pain Relief Patch's effectiveness for chronic back pain using specific light wavelengths.
The CPPF therapy study was terminated despite showing safety and efficacy in reducing postoperative bleeding after cardiac surgery.
A completed trial assessed the cost-effectiveness of a novel anal device for fecal incontinence.
A clinical trial is recruiting to validate StrokePointer, an EEG device for triaging LVO stroke patients in ambulances.
A study showed a 1-lead ECG device can reduce emergency department visits for atrial fibrillation post-pulmonary vein isolation.
The study evaluates the Trachospray device for effective airway anaesthesia during awake videolaryngoscopy.
A study validated a smartphone-connected ECG device for screening asymptomatic atrial fibrillation in seniors 65+.
Research identifies cellular damage in the olfactory system as an early indicator of Alzheimer's disease.
ASML remains a dominant player in the semiconductor manufacturing equipment sector, facing challenges ahead.
ASML faces limited customers as Taiwan Semiconductor claims its high-end machine is too costly.
Kurma Partners raised €215M for its fourth biotech fund to support 20 European startups.
CHMP recommended 12 new medicines for approval at its February 2026 meeting.
BD partners with Sinteco to automate sorting of pharmaceutical shipments in European hospitals.